Jeff Baxter Leaves Column Group for Variation Biotech

Jeff Baxter has joined Variation Biotechnologies Inc. as chief executive officer. He previously was a managing partner with VC firm The Column Group.

22 September 2009•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles